Dr. Rajesh Movva, MD

Dr. Movva practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Movva's NPI, 1326104738, was assigned on December 29, 2006. Dr. Movva holds Pennsylvania license MD432138.

Dr. Movva's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Dr. Movva's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Movva is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Einstein Gastroenterology Associates. Dmand AI also links Dr. Movva to 3 more hospitals, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Movva practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Movva's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Movva's licenses on file in 2 states: Pennsylvania and Washington.

CMS data shows 1,351 Medicare services from Dr. Movva across 14 procedure codes in 2024, for 705 Medicare patients. Medicare paid $63,099 for them.

CMS counts 705 Medicare patients who saw Dr. Movva in 2024. The largest group is 65 to 74, with 305 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Movva's median patient age at 69, with 52% women.

In 2024, Dr. Movva wrote 1,121 Medicare Part D claims for 225 patients. 85% of them were for generic drugs. CMS names the drug for 1,065 of them, across 23 drugs with 11 or more claims each, at $176,425 in total drug cost. In 2023, CMS named 412 claims across 12 drugs.

Dr. Movva accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Movva, published from 2012 to 2016. 2012 was the busiest year, with 5. The most frequent topics are Calcinosis, Mitral Valve and Mitral Valve Insufficiency. Dr. Movva has published most often in Echocardiography. Dr. Movva's most frequent co-authors are Vincent Michael Figueredo, MD, Richard Louis Dunbar, MD and Peter Fumo, MD.

CMS Open Payments shows 37 general payments to Dr. Movva from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $237.